Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 4Dermatologic 4Breast 3Head & Neck 2Genitourinary 2Thoracic 1Plasma cell 1Lymphoid 1Gynecologic 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5Melanoma 3Breast Neoplasms 3Sarcoma 2Head and Neck Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma 1Kidney Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma 1

Interventions

pembrolizumab 11Nivolumab 6Cetuximab 5Gemcitabine 4Filgrastim 4Cisplatin 4Carboplatin 4tislelizumab 3Radiosurgery 3Ipilimumab 3Injections 3Fluorouracil 3Docetaxel 3Cyclophosphamide 3Bortezomib 3toripalimab 2spartalizumab 2poly ICLC 2pazopanib 2entrectinib 2durvalumab 2cemiplimab 2belinostat 2atezolizumab 2Temozolomide 2Surveys and Questionnaires 2Riluzole 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × poly ICLC × Head & Neck × Clear all
NCT02643303 2022-12-02

A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Ludwig Institute for Cancer Research

Phase 1/2 Completed
58 enrolled 24 charts
BreastDermatologicGenitourinaryHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Kidney Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Lymphoma, T-Cell, Cutaneous

NCT02423863 2020-12-17

Poly-ICLC

Oncovir, Inc.

Phase 2 Completed
26 enrolled
DermatologicHead & NeckSarcoma

Head and Neck Neoplasms, Melanoma, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡